The primary objective is to evaluate the efficacy of Euglycem® plus recommended standard diet on reducing FPG compared to baseline and to recommended standard diet alone after 3 months
BMI ≤30 kg/m2
subjects able to understand the informed consent and sign it before enrollment in the study
subjects willing to follow all study requirements and perform all study visits as well as collaborate with the investigator.
ongoing treatment with drugs that can affect blood glucose
current participation in another investigational drug or investigational device trial or inclusion in another investigational drug or investigational device trial within the previous month